戻る Agenda
Session 1: The Big Picture
Session Chair(s)
Sven Schirp
Head of Global Pharmacovigilance Writing
Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
- Introduction of PV documents from beginning of clinical development until the withdrawal of marketing authorization: The story from beginning to end.